nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—Malnutrition—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Desvenlafaxine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Desvenlafaxine—Syncope—Mycophenolic acid—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Desvenlafaxine—Fatigue—Captopril—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Desvenlafaxine—Anxiety—Leflunomide—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Desvenlafaxine—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Desvenlafaxine—Constipation—Captopril—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Desvenlafaxine—Tension—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Desvenlafaxine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Desvenlafaxine—Dysgeusia—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Desvenlafaxine—Skin disorder—Azathioprine—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Desvenlafaxine—Nervousness—Lisinopril—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Desvenlafaxine—Dry mouth—Leflunomide—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Desvenlafaxine—Vomiting—Pentoxifylline—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Desvenlafaxine—Convulsion—Mycophenolic acid—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Desvenlafaxine—Rash—Pentoxifylline—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Desvenlafaxine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Desvenlafaxine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Desvenlafaxine—Headache—Pentoxifylline—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Desvenlafaxine—Vision blurred—Lisinopril—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Asthenia—Mometasone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Irritability—Prednisone—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Desvenlafaxine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Desvenlafaxine—Tremor—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Desvenlafaxine—Tachycardia—Leflunomide—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Desvenlafaxine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Desvenlafaxine—Skin disorder—Leflunomide—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Desvenlafaxine—Angioedema—Lisinopril—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Desvenlafaxine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Desvenlafaxine—Nausea—Pentoxifylline—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Desvenlafaxine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Desvenlafaxine—Vertigo—Lisinopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Desvenlafaxine—Diarrhoea—Mometasone—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Desvenlafaxine—Syncope—Lisinopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Desvenlafaxine—Shock—Mycophenolic acid—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Desvenlafaxine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Desvenlafaxine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Desvenlafaxine—Palpitations—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Desvenlafaxine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Desvenlafaxine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Desvenlafaxine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.002	0.002	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Desvenlafaxine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Desvenlafaxine—Insomnia—Leflunomide—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Desvenlafaxine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Desvenlafaxine—Paraesthesia—Leflunomide—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Desvenlafaxine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Desvenlafaxine—Anxiety—Lisinopril—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Desvenlafaxine—Vomiting—Mometasone—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Desvenlafaxine—Dry mouth—Lisinopril—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Desvenlafaxine—Rash—Mometasone—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Desvenlafaxine—Asthenia—Captopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Desvenlafaxine—Dermatitis—Mometasone—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Desvenlafaxine—Decreased appetite—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Desvenlafaxine—Headache—Mometasone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Desvenlafaxine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Desvenlafaxine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Desvenlafaxine—Fatigue—Leflunomide—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Desvenlafaxine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Desvenlafaxine—Constipation—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Desvenlafaxine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Desvenlafaxine—Shock—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Desvenlafaxine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Desvenlafaxine—Tachycardia—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Desvenlafaxine—Skin disorder—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Diarrhoea—Captopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Irritability—Methotrexate—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Desvenlafaxine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Desvenlafaxine—Nausea—Mometasone—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisone—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Desvenlafaxine—Constipation—Mycophenolic acid—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Desvenlafaxine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Desvenlafaxine—Weight decreased—Prednisone—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Desvenlafaxine—Dizziness—Captopril—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Desvenlafaxine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Desvenlafaxine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Breast disorder—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Insomnia—Lisinopril—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Desvenlafaxine—Paraesthesia—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Desvenlafaxine—Vomiting—Captopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Desvenlafaxine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Desvenlafaxine—Rash—Captopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Desvenlafaxine—Dermatitis—Captopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Desvenlafaxine—Somnolence—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Desvenlafaxine—Headache—Captopril—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Desvenlafaxine—Decreased appetite—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Desvenlafaxine—Fatigue—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Desvenlafaxine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Leflunomide—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Desvenlafaxine—Constipation—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Desvenlafaxine—Diarrhoea—Azathioprine—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Desvenlafaxine—Nausea—Captopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Desvenlafaxine—Asthenia—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Desvenlafaxine—Hallucination—Prednisone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Desvenlafaxine—Dizziness—Azathioprine—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Desvenlafaxine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Desvenlafaxine—Diarrhoea—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Desvenlafaxine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Desvenlafaxine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Desvenlafaxine—Vomiting—Azathioprine—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Desvenlafaxine—Eye disorder—Prednisone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Desvenlafaxine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Desvenlafaxine—Rash—Azathioprine—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Desvenlafaxine—Dermatitis—Azathioprine—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Desvenlafaxine—Headache—Azathioprine—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Desvenlafaxine—Dizziness—Leflunomide—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Desvenlafaxine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Desvenlafaxine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Desvenlafaxine—Angiopathy—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Desvenlafaxine—Immune system disorder—Prednisone—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Desvenlafaxine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Desvenlafaxine—Vomiting—Leflunomide—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Desvenlafaxine—Alopecia—Prednisone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Rash—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Dermatitis—Leflunomide—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Mental disorder—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Nausea—Azathioprine—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Desvenlafaxine—Headache—Leflunomide—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Desvenlafaxine—Malnutrition—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Desvenlafaxine—Asthenia—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Desvenlafaxine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Desvenlafaxine—Rash—Mycophenolic acid—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Desvenlafaxine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Desvenlafaxine—Headache—Mycophenolic acid—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Desvenlafaxine—Nausea—Leflunomide—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Desvenlafaxine—Vision blurred—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Desvenlafaxine—Diarrhoea—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Desvenlafaxine—Dizziness—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Desvenlafaxine—Nausea—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Desvenlafaxine—Syncope—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Vomiting—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Desvenlafaxine—Rash—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Desvenlafaxine—Dermatitis—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Headache—Lisinopril—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Desvenlafaxine—Anxiety—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Desvenlafaxine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Desvenlafaxine—Nausea—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Desvenlafaxine—Shock—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Desvenlafaxine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Desvenlafaxine—Skin disorder—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Desvenlafaxine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Desvenlafaxine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Desvenlafaxine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Desvenlafaxine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisone—systemic scleroderma	0.001	0.001	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisone—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Desvenlafaxine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000971	0.000971	CcSEcCtD
Desvenlafaxine—Decreased appetite—Prednisone—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Desvenlafaxine—Fatigue—Prednisone—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Desvenlafaxine—Constipation—Prednisone—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisone—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Desvenlafaxine—Asthenia—Prednisone—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Desvenlafaxine—Diarrhoea—Prednisone—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisone—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Desvenlafaxine—Vomiting—Prednisone—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Desvenlafaxine—Rash—Prednisone—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisone—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Desvenlafaxine—Headache—Prednisone—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Desvenlafaxine—Asthenia—Methotrexate—systemic scleroderma	0.000664	0.000664	CcSEcCtD
Desvenlafaxine—Nausea—Prednisone—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methotrexate—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—systemic scleroderma	0.000612	0.000612	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—systemic scleroderma	0.00055	0.00055	CcSEcCtD
